EN DE

Guangzhou Jointas Chemical Co (002909) Fair Value & Analysis

Basic Materials · CN · Market cap 1.9B CNY

GJ Guangzhou Jointas Chemical Co 002909 · SHE
Price¥5.16
Fair Value¥2.44
Upside-52.7%
Quality33/100
Watch Guangzhou Jointas Chemical Co for free, get notified when fair value or trend changes. Watch for free
Expensive Growth
Loss-making · -3.3% net margin
Low debt · negative free cash flow
Trails peers (3/11)
Narrow moat 12/100
Evidence: Low Range ¥1.18 – ¥3.72 Share as image

Fair value as of: Aug 7, 2026

From 6 valuation models · updated 4 days ago

Fair value updated Aug 7, 2026, revised from ¥1.22 to ¥2.44 (+100.0%) since Jul 22, 2026. Share price +7.5% over the past month.

Below-average quality, and screening another 53% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case (¥3.72). The favourable scenario is already priced in.
  • Weak quality (33/100) and above fair value at the same time, the margin of safety is missing on both counts.
  • The model range is unusually wide (¥1.18 to ¥3.72). The outcome hinges heavily on assumptions, so read the point estimate with caution.
  • The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

¥19.16 ¥3.51 Fair Value ¥2.44 Mar 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 7, 2026.

How to read this chart

60‑month range ¥3.51 – ¥19.16 · fair‑value band ¥1.18 – ¥3.72 · the ¥5.16 price screens above the ¥2.44 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 7, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Guangzhou Jointas Chemical Co (002909) currently trades at ¥5.16, while our model-based Fair Value estimate is ¥2.44, implying the stock looks roughly 52.7% overvalued today. The Quality Score stands at 33/100 (below-average quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).

Over the trailing twelve months, Guangzhou Jointas Chemical Co generated revenue of 1.0B CNY at a net margin of -3.3%. Revenue declined 14.9% year over year. It earns a return on equity of -4.0%. Net debt stands at 511M CNY. Fundamentals as of Aug 7, 2026

Our scenario range runs from ¥1.18 (bear case) to ¥3.72 (bull case); at ¥5.16, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 42% below its 52-week high, currently below its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -58% fair-value upside, at -53%, 002909 screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Note: the current price implies far more future growth than the conservative anchors of our models allow (base growth is deliberately capped, we do not regard such extreme rates as sustainable). Our models are not designed for expectations this high; that is why the individual models scatter extremely (¥0.2300 to ¥2.31). Read the values as a conservative anchor, not as a price target.
Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
ROIC Compounder ¥0.1700 ¥0.2300 ¥0.2700 72
EPV ¥0.1700 ¥0.2300 ¥0.2700 59
EV/EBITDA ¥1.68 ¥2.31 ¥2.94 54
All 6 models by family
Earnings-Based
EPV ¥0.1700 ¥0.2300 ¥0.2700 59
Multiples
EV/EBIT ¥0.3600 ¥0.5500 ¥0.7400 53
EV/EBITDA ¥1.68 ¥2.31 ¥2.94 54
EV/Revenue ¥0.2800 ¥0.4900 ¥0.7100 43
Asset-Based
NCAV (Graham) ¥1.11 ¥1.48 ¥2.21 50
Economic Profit
ROIC Compounder ¥0.1700 ¥0.2300 ¥0.2700 72

Widest divergence: Asset-Based (¥1.48) versus Earnings-Based (¥0.2300). Highest evidence: ROIC Compounder (72).

Notify me when 002909 reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 1.0B CNY
Revenue growth (YoY) -14.9%
Net margin -3.3%
Return on equity -4.0%
Free cash flow −141M CNY FY2025
Operating margin -3.9%
More key figures
EPS (TTM) ¥-0.0900
EPS growth (YoY) -54.2%
Net debt 511M CNY FY2025

Figures from reported company fundamentals · as of Aug 7, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 33/100

Of which business quality 34 · Market factors (momentum, volatility) 29

Profitability 15
Margins and returns on capital today
Quality Growth 32
Are margins and returns improving?
Cashflow 15
Earnings quality: real cash, not paper profit
Fin. Strength 29
Balance sheet, leverage, solvency risk
Investment 57
Disciplined investing over empire-building
Low Volatility 70
Calm price path (market factor)
Momentum 10
Price trend over the last 3–12 months (market factor)
52W Momentum 17
Distance to the 52-week high (market factor)
Net Issuance 81
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Guangzhou Jointas Chemical Co., Ltd. engages in the research, development, production, and sales of adhesives in China. Its products are used in construction, containers, automobiles/electric vehicles, electronics, transportation, petrochemical equipment, steel structures, and engineering equipment. It sells its products under the Antai and Jitai brands.

Full company description

Guangzhou Jointas Chemical Co., Ltd. engages in the research, development, production, and sales of adhesives in China. Its products are used in construction, containers, automobiles/electric vehicles, electronics, transportation, petrochemical equipment, steel structures, and engineering equipment. It sells its products under the Antai and Jitai brands. Guangzhou Jointas Chemical Co., Ltd. was founded in 1989 and is based in Guangzhou, China.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Guangzhou Jointas Chemical Co reported revenue of ¥1.1B in FY2025 versus ¥1.7B in FY2021, a compound −10.3%/yr. Reported net income was −¥27.7M in FY2025.

Growth Quality 16/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Latest Revenue (FY 2025)
1.1B CNY
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−8.5%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+4.8%
Avg. growth/yr (12Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+10.0%
Revenue −10.3%/yr
FY21 ¥1.7B
FY22 ¥1.5B
FY23 ¥1.3B
FY24 ¥1.3B
FY25 ¥1.1B
Net income
FY21 ¥50.7M
FY22 ¥10.2M
FY23 ¥10.2M
FY24 ¥19.3M
FY25 −¥27.7M

002909 screens 53% overvalued. Compare with Linde plc →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Guangzhou Jointas Chemical Co Fair Value". https://www.fairvalue-calculator.com/stock/002909

Peer Group

Specialty Chemicals · 673 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 33 · Bottom 25%
Fair Value upside −53% · Below median
Return on assets -0% · Bottom 25%
Net margin (TTM) -3% · Bottom 25%
Operating margin (TTM) -4% · Bottom 25%
Revenue growth -15% · Bottom 25%
Debt / equity 0.25× · Higher than median

Valuation Multiples vs Specialty Chemicals median · lower = cheaper

P/B 0.33× · Cheaper than 75% of peers
P/S (TTM) 0.27× · Cheaper than 75% of peers
EV/EBITDA 5.5× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 0
FUTURE 0 · sector 19
PAST 0 · sector 23
HEALTH 88 · sector 95
DIVIDEND 0 · sector 25

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Aug 7, 2026).

Stock Price Fair Value vs Fair Value
Linde plc LIN $489.98 $222.03 -55%
Nan Ya Plastics Corporation 1303 181.50 TWD 255.83 TWD +41%
Wanhua Chemical Group 600309 ¥70.04 ¥68.03 -3%
Novozymes A/S NSISB kr 428.20 kr 179.66 -58%
Asian Paints Limited ASIANPAINT ₹2,689 ₹668.81 -75%
Solar Industries India Limited SOLARINDS ₹18,236 ₹2,793 -85%
Pidilite Industries Limited PIDILITIND ₹1,560 ₹351.84 -77%
PT Chandra Asri Pacific Tbk TPIA 1,805 IDR 2,888 IDR +60%
Linde India Limited LINDEINDIA ₹7,115 ₹757.93 -89%
Berger Paints India Limited BERGEPAINT ₹493.70 ₹164.29 -67%

Compare Guangzhou Jointas Chemical Co with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Guangzhou Jointas Chemical Co (002909) overvalued or undervalued?
As of Aug 7, 2026, our model estimates a fair value of ¥2.44 versus a price of ¥5.16, about −53% (overvalued).
What is the fair value of 002909?
Our model-based fair value for Guangzhou Jointas Chemical Co is ¥2.44 (as of Aug 7, 2026), built from audited fundamentals. The current price is ¥5.16.
What is the quality score of 002909?
Guangzhou Jointas Chemical Co has a Quality Score of 33/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Guangzhou Jointas Chemical Co (002909)?
Guangzhou Jointas Chemical Co reported trailing-twelve-month revenue of about 1.0B CNY (latest available figure, as of Aug 7, 2026).
What is the net profit margin of 002909?
The net profit margin of Guangzhou Jointas Chemical Co is about -3.3%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Guangzhou Jointas Chemical Co and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.